Performance of European Member States in biotechnology

Science and Public Policy

Volumn 31, Issue 5, 2004, Pages 344-358

  Reiss, Thomas ^a   Hinze, Sibylle ^a   Lacasa, Iciar Dominguez ^a  

^a FRAUNHOFER INSTITUTE FOR SYSTEMS AND INNOVATION RESEARCH ISI   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; HIGH TECHNOLOGY INDUSTRY; INDUSTRIAL PERFORMANCE; SCIENCE AND TECHNOLOGY;

EASTERN HEMISPHERE; EURASIA; EUROPE; WORLD;

EID: 7044226399     PISSN: 03023427     EISSN: None     Source Type: Journal    
DOI: 10.3152/147154304781779822     Document Type: Article

References (25)

1. Allansdottir, A, A Bonaccorsi, A Gambardella, M Mariani, L Orsenigo, F Pammolli, and M Riccaboni (2002), "Innovation and competitiveness in the European Biotechnology", Enterprise Papers no 7, report commissioned by the European Commission, DG Enterprise, as background paper for the Competitiveness Report 2001.
2. Dodgson, M, and S Hinze (2000), "Indicators used to measure the innovation process: defects and possible remedies", Research Evaluation, 8(2), pages 101-114.
3. Enzing, C, J Benedictus, E Engelen-Smeets, J Senker, P Martin, T Reiss, H Schmidt, G 'Assouline, P B Joly and L Nesta (1999), Inventory of Public Biotechnology R&D Programmes in Europe, three volumes (Office for Official Publications of the European Communities, Luxembourg).
4. Enzing, C M, A M van der Giessen and S J Kern (2002), Life Sciences in Nederland: Economische Betekenis, Technologische Trends en Scenario's voor de Toekomst, STB-02-23 (TNO-STB, Netherlands Organisation for Applied Science Research, Strategy, Technology and Policy, Delft).
5. Ernst and Young (2001a), Integration - Eighth Annual European Life Sciences Report 2001 (Ernst and Young, London).
6. Ernst and Young (2001b), Focus on Fundamentals. The Biotechnology Report (Ernst and Young, New York).
7. European Commission (1995), Green paper on Innovation (European Commission, Luxembourg).
8. European Commission (2001), European Competitiveness Report (European Commission, Luxembourg: Eur-Op, catalogue no NB-39-01-110-EN-CEN).
9. European Commission (2002), Life Sciences and Biotechnology - a strategy for Europe (European Commission, Brussels) available at , last accessed 9 September 2004.
10. European Commission (2003a), Biotechnology Innovation Scoreboard 2003 European Trend Chart on Innovation (DG Enterprise, Brussels) available at , last accessed 9 September 2004.
11. European Commission (2003b), Third European Report on Science and Technology Indicators 2003 (Office for Official Publications of the European Communities, Luxembourg).
12. EVCA (2002), Yearbook 2002 - Annual Survey 2001 (ECVA, Brussels).
13. EVCA (2003), Yearbook 2003 - Annual Survey 2002 (ECVA, Brussels).
14. Hermans, R, and T Luukkonen (2002), "Findings of the ETLA survey on Finnish biotechnology firms", ETLA, The Research Insitute of The Finnish Economy, Helsinki, discussion paper no 819.
15. Lheureux, K, M Libeau-Dulos, H Nilsagård, E Rodriguez Cerezo, K Menrad, M Menrad and D Vorgrimmler (2003), Review of GMOs under Research and Development and in the Pipeline in Europe (European Commission, Joint Research Centre, Institute for Prospective Technological Studies (IPTS), Seville).
16. Luukkonen, T, O Person and G Sivertsen (1992), "Understanding patterns of international scientific collaboration", Science, Technology and Human Values, 17, pages 101-126.
17. Mangematin, V, S Lemarie, J P Boissin, D Catherine, F Corolleur, R Coronini and M Trommetter (2003), "Sectoral system of innovation, SMEs development and heterogeneity of trajectories", Research Policy, 32(4), pages 621-638.
18. McKelvey, M, H Alm and M Riccaboni (2003), "Does co-location matter for formal knowledge collaboration in the Swedish biotechnology-pharmaceutical sector?", Research Policy, 32, pages 483-501.
19. Narin, F, G Pinski and H Hofer Gee (1976), "Structure of the biomedical literature", JASIS, 27(1), pages 25-45.
20. OECD, Organisation for Economic Co-operation and Development (2002), A Statistical Framework for Biotechnology Statistics, DSTI/EAS/STP/NESTI (2001) 3. REV 3 (OECD, Paris).
21. Reiss, T, J Calvert, I Dominguez Lacasa, C Enzing, A van der Giessen, S Hinze, S Kern, V Mangematin, L Nesta, P Patel and J Senker (2003), Efficiency of Innovation Policies in High Technology Sectors in Europe (EPOHITE), EUR 20904 (Final report), EUR 29022 (National Case Studies), September (Office for Official Publications of the European Communities, Luxembourg.
22. Sandström, A, and L Norgren (2003), Swedish Biotechnology - scientific publications, patenting and industrial development, VINNOVA Analysis VA 2003:2.
23. Sandström, A, I Pettersson and A Nilsson (2000), "Knowledge production and knowledge flows in the Swedish biotech innovation system", Scientometrics, 48(2), pages 179-201.
24. Schmoch, U (2004), "Leistungsfähigkeit und Strukturen der Wissenschaft im internationalen Vergleich. Analysen im Rahmen der jährlichen Berichterstattung der technologischen Leistungsfähigkeit Deutschlands", Studien zum Innovations-system 13 (Fraunhofer ISI, Karlsruhe).
25. Senker, J, P van Zwanenberg, C Enzing, S Kern, V Mangematin, R Martinsen, E Munoz, V Diaz, S O'Hara, K Burke, T Reiss and S Wörner (2001), European Biotechnology Innovation System (European Commission, Brussels).